Similar articles

• The case for early combined hormonal and cytostatic treatment for metastatic prostatic carcinoma.

  Servadio C. Servadio C. Prog Clin Biol Res. 1987;243B:449-53. Prog Clin Biol Res. 1987. PMID: 3659039 No abstract available.
• Can prostatectomy add any benefit to the hormonal treatment of stage C prostatic carcinoma?

  Schröder FH. Schröder FH. Prog Clin Biol Res. 1989;303:241-52. Prog Clin Biol Res. 1989. PMID: 2780650 No abstract available.
• Complete androgen blockade: the EORTC experience comparing orchidectomy versus orchidectomy plus cyproterone acetate versus low-dose stilboestrol in the treatment of metastatic carcinoma of the prostate.

  Robinson MR. Robinson MR. Prog Clin Biol Res. 1987;243A:383-90. Prog Clin Biol Res. 1987. PMID: 2958863 Clinical Trial. No abstract available.
• Simultaneous endocrine management and chemotherapy as initial treatment in M1 prostatic carcinoma.

  Richards B. Richards B. Prog Clin Biol Res. 1988;269:177-86. Prog Clin Biol Res. 1988. PMID: 2839846 Review. No abstract available.
• Total androgen suppression: are there any advantages? The use of combined therapy in the treatment of advanced prostate adenocarcinoma.

  Foote JE, Crawford ED. Foote JE, et al. Semin Urol. 1988 Nov;6(4):291-302. Semin Urol. 1988. PMID: 3068767 Review. No abstract available.